We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M Turnover 20%
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-32.15%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$293M
AUM Growth
-$170M
Cap. Flow
-$5.33M
Cap. Flow %
-1.82%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
–
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.8 years

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ITOS icon
iTeos Therapeutics
ITOS
+$5.33M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ITOS icon
1
DELISTED
iTeos Therapeutics
ITOS
$88.1M 30.12%
2,738,785
-146,685
-5% -$5.33M
2020 Q3
6 quarters
DYN icon
2
Dyne Therapeutics
DYN
$2.81B
$47.7M 16.31%
4,951,303
– –
2020 Q3
6 quarters
TRDA icon
3
Entrada Therapeutics
TRDA
$177M
$41.6M 14.2%
4,425,784
– –
2021 Q4
1 quarter
RPTX icon
4
DELISTED
Repare Therapeutics
RPTX
$31.9M 10.92%
2,242,636
– –
2020 Q2
7 quarters
AMYT
5
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$22.1M 7.54%
2,668,843
– –
2021 Q3
2 quarters
HOWL icon
6
Werewolf Therapeutics
HOWL
$47.6M
$18.9M 6.44%
4,284,172
– –
2021 Q2
3 quarters
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$15.6M 5.32%
313,139
– –
2019 Q1
12 quarters
TCRR
8
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$11.2M 3.82%
4,050,865
– –
2019 Q1
12 quarters
RYTM icon
9
Rhythm Pharmaceuticals
RYTM
$5.97B
$10.5M 3.58%
909,258
– –
2017 Q4
17 quarters
ONCR
10
DELISTED
Oncorus, Inc.
ONCR
$5.07M 1.73%
2,849,464
– –
2020 Q4
5 quarters

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, MPM Asset Management held 10 positions worth $293M, down 37% from $463M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. MPM Asset Management opened no new positions and made no exits, leaving the 10-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's biggest Q1 2022 reduction was iTeos Therapeutics, cutting an estimated $5.33M.
  • MPM Asset Management's ten largest holdings make up 100% of its $293M portfolio in Q1 2022.
  • MPM Asset Management opened 0 new positions and closed 0 in Q1 2022.
  • MPM Asset Management's portfolio value fell 37% quarter-over-quarter to $293M.

Based on MPM Asset Management's 13F filing for Q1 2022, filed 13 May 2022.